{
    "organizations": [],
    "uuid": "29785b1fab37642771711ba1e36881516580509a",
    "author": "",
    "url": "https://www.reuters.com/article/abbvie-study/abbvie-says-not-seeking-accelerated-approval-for-lung-cancer-drug-idUSL3N1R44OX",
    "ord_in_thread": 0,
    "title": "AbbVie says not seeking accelerated approval for lung cancer drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 12:58 PM / Updated 9 minutes ago AbbVie says not seeking accelerated approval for lung cancer drug Reuters Staff 1 Min Read March 22 (Reuters) - Drugmaker AbbVie Inc said on Thursday it will not seek accelerated approval for its experimental lung cancer treatment based on results from a mid-stage study. The study was testing the company’s Rova-T as a treatment for patients with small cell lung cancer who did not respond to at least two prior regimens. Late-stage trials testing the drug as a treatment for patients in the earlier stages of the disease will continue, the company said. (Reporting by Tamara Mathias in Bengaluru; Editing by Anil D’Silva)",
    "published": "2018-03-22T14:57:00.000+02:00",
    "crawled": "2018-03-22T15:15:40.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "abbvie",
        "say",
        "seeking",
        "accelerated",
        "approval",
        "lung",
        "cancer",
        "drug",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "drugmaker",
        "abbvie",
        "inc",
        "said",
        "thursday",
        "seek",
        "accelerated",
        "approval",
        "experimental",
        "lung",
        "cancer",
        "treatment",
        "based",
        "result",
        "study",
        "study",
        "testing",
        "company",
        "treatment",
        "patient",
        "small",
        "cell",
        "lung",
        "cancer",
        "respond",
        "least",
        "two",
        "prior",
        "regimen",
        "trial",
        "testing",
        "drug",
        "treatment",
        "patient",
        "earlier",
        "stage",
        "disease",
        "continue",
        "company",
        "said",
        "reporting",
        "tamara",
        "mathias",
        "bengaluru",
        "editing",
        "anil",
        "silva"
    ]
}